In this situation of public health emergency, it is of major interest for the Union that safe and efficacious medicinal products intended to treat or prevent COVID-19 can be developed and be made available within the Union as soon as possible.
Recital 13, Regulation (EU) 2020/1043
In forcesince 15 Jul 2020